This page shows the latest Constellation Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
German biopharma company MorphoSys has announced that it will acquire Constellations Pharmaceuticals, a clinical-stage company with expertise in epigenetics, for a total of $1.7bn. ... The funds will be used to support MorphoSys’ acquisition of
tumours. The acquisition is Merck's second this month after it agreed an $8.4bn takeover deal with anti-infectives specialist Cubist Pharmaceuticals. ... Other companies working in the BET inhibitor area include GlaxoSmithKline (GSK) with I-BET762, also
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Immuno-oncology combinations in lung cancer. Not disclosed. Peregrine Pharmaceuticals. Combination clinical trials. ... This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
US-based Constellation Pharmaceuticals has appointed Emma Reeve as its chief financial officer to bolster the biopharma’s finance efforts. ... Additionally, Brad Prosek (pictured left) joins Constellation Pharmaceuticals as senior vice president,
Appointments include Adrian Senderowicz as chief medical officer. Cambridge, UK-based Constellation Pharmaceuticals has appointed Adrian Senderowicz as its senior vice president and chief medical officer. ... He said: “Constellation Pharmaceuticals is
US firm has also bolstered its scientific advisory board. Constellation Pharmaceuticals has appointed Jigar Raythatha as its new chief executive officer (CEO) and president in a role that marks his return ... Mark Goldsmith, executive chairman of
More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...